4//SEC Filing
Li Zhilin 4
Accession 0001213900-21-047830
CIK 0001106644other
Filed
Sep 12, 8:00 PM ET
Accepted
Sep 13, 9:19 PM ET
Size
5.3 KB
Accession
0001213900-21-047830
Insider Transaction Report
Form 4
Li Zhilin
DirectorCEO & Interim CFO10% Owner
Transactions
- Award
Common Stock
2021-09-09$0.67/sh+1,760,000$1,179,200→ 13,810,000 total
Footnotes (1)
- [F1]On September 9, 2021, the reporting person was granted 1,760,000 shares of Issuer's common stock under the Issuer's 2010 Long-Term Incentive Plan, vesting immediately with no restrictions, as partial offset of her accrued but unpaid cash compensation by serving as the Issuer's Chairman of the Board, Chief Executive Officer and interim Chief Financial Officer.
Documents
Issuer
CHINA PHARMA HOLDINGS, INC.
CIK 0001106644
Entity typeother
Related Parties
1- filerCIK 0001342188
Filing Metadata
- Form type
- 4
- Filed
- Sep 12, 8:00 PM ET
- Accepted
- Sep 13, 9:19 PM ET
- Size
- 5.3 KB